Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody–drug conjugates - Xuefei Bai; Lingyi Xu; Zhe Wang; Xinlei Zhuang; Jiangtao Ning; Yanping Sun; Haibin Wang; Yugang Guo; Yingchun Xu; Jiangtao Guo; Shuqing Chen; Liqiang Pan (Proceedings of the National Academy of Sciences, 2025)